Epilepsy

Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.

One-year results from the PREVAIL OLE extension trial discuss the safety and efficacy of topiramate for refractory partial onset seizures.

Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.

Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

How do you respond when a patient with epilepsy asks about the safety of pregnancy? The WEPOD study investigated pregnancy outcomes and deliveries.

Can use of an online platform improve patient self-management in a group of Veterans with epilepsy?

Researchers studied the prevalence and incidence of epilepsy in the elderly and confirmed three risk factors in this patient population.

To improve the quality of care for patients with epilepsy, AAN updated a set of measures and guidelines in 2014, but does a gap still exist?

Although extremely premature boys tend to have a higher burden of neurocognitive impairments than girls, some unexpected similarities were found.

Cannabis may be useful for some types of refractory epilepsy, but few controlled studies with objective measures of efficacy and side effects exist.

Updated guidelines incorporate epilepsy drugs developed since the last protocol and include an evidence-based treatment algorithm.

Technology that is efficient yet lacking side effects, personalized, and nonintrusive may be closer than we think for many of our neurology patients.

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

When evaluating dietary therapy in patients with GLUT1 deficiency syndrome, did the ketogenic diet prove more effective than the alternatives?

Our Jan. news & research list includes the possible lingering effects of childhood concussion and the benefits of vitamin D for MS.

An open-label study looked at add-on cannabidiol in children and young adults with severe, intractable, childhood-onset treatment-resistant epilepsy.

Does it matter whether the medications we prescribe to patients are generated via the most cutting edge 3D printing technology?

Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.

Highlights of recent pediatric epilepsy research include a minimally invasive surgical procedure and genetic testing.

Researchers discussed external devices that would allow individuals to monitor clinical and subclinical seizure activity in their home environment

Results of an MRI study and a 50-year follow-up study shed light on the effects of epilepsy on the brain’s aging process.

Researchers demonstrated promising results in surgical treatment of epileptic encephalopathy and refractory epilepsy.

What exactly should physicians do when presented with interictal epileptiform discharges (IEDs), or spikes?

Important bioequivalence issues regarding anti-epileptic drugs were highlighted at the FDA Town Hall meeting held during AES 2015.